Making opoids more effective pain killers
Low intrinsic efficacy can explain the reduced side effects of new agonists of the m-opioid receptor a British-Australian reseach team reports.
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1377 entries already.
Low intrinsic efficacy can explain the reduced side effects of new agonists of the m-opioid receptor a British-Australian reseach team reports.
Austrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients
The European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting.
Scandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism.
Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test.
AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company.
Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease.
Evonik Industries has established a new animal-free and fermentation-based industrial-scale recombinant collagen production platform.
Chinese Fosun Pharma Ltd has made the largest investment in a foreign company for a COVID-19 vaccine development: BioNTechd mRNA vaccine BNT162.
Under its Green Deal, the European Commission has presented a circular (bio)economay action plan that prepares the ground for a sustainable bio-economy.
